Raily Aesthetic Medicine International Holdings Beheer
Beheer criteriumcontroles 3/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Jianliang Song
Algemeen directeur
CN¥933.0k
Totale compensatie
| Percentage CEO-salaris | 96.5% |
| Dienstverband CEO | 2.9yrs |
| Eigendom CEO | n/a |
| Management gemiddelde ambtstermijn | 3.5yrs |
| Gemiddelde ambtstermijn bestuur | 3.9yrs |
Recente managementupdates
Recent updates
Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Held Back By Insufficient Growth Even After Shares Climb 37%
Oct 02
Benign Growth For Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Underpins Its Share Price
Jul 22Revenues Working Against Raily Aesthetic Medicine International Holdings Limited's (HKG:2135) Share Price Following 47% Dive
Apr 22Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Stock Rockets 39% As Investors Are Less Pessimistic Than Expected
Feb 07Raily Aesthetic Medicine International Holdings Limited's (HKG:2135) Popularity With Investors Is Under Threat From Overpricing
Dec 19Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Investors Are Less Pessimistic Than Expected
Aug 22Statutory Profit Doesn't Reflect How Good Raily Aesthetic Medicine International Holdings' (HKG:2135) Earnings Are
Sep 17Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -CN¥32m |
| Mar 31 2024 | n/a | n/a | -CN¥32m |
| Dec 31 2023 | CN¥933k | CN¥900k | -CN¥32m |
| Sep 30 2023 | n/a | n/a | -CN¥26m |
| Jun 30 2023 | n/a | n/a | -CN¥20m |
| Mar 31 2023 | n/a | n/a | -CN¥18m |
| Dec 31 2022 | CN¥647k | CN¥600k | -CN¥16m |
| Sep 30 2022 | n/a | n/a | -CN¥13m |
| Jun 30 2022 | n/a | n/a | -CN¥11m |
| Mar 31 2022 | n/a | n/a | -CN¥14m |
| Dec 31 2021 | CN¥1m | CN¥1m | -CN¥18m |
| Sep 30 2021 | n/a | n/a | -CN¥3m |
| Jun 30 2021 | n/a | n/a | CN¥11m |
| Mar 31 2021 | n/a | n/a | CN¥8m |
| Dec 31 2020 | CN¥1m | CN¥1m | CN¥4m |
| Sep 30 2020 | n/a | n/a | -CN¥25k |
| Jun 30 2020 | n/a | n/a | -CN¥4m |
| Mar 31 2020 | n/a | n/a | CN¥3m |
| Dec 31 2019 | CN¥2m | CN¥2m | CN¥10m |
Compensatie versus markt: De totale vergoeding ($USD 128.73K ) Jianliang } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de Hong Kong markt ($USD 232.96K ).
Compensatie versus inkomsten: De vergoeding van Jianliang is gestegen terwijl het bedrijf verliesgevend is.
CEO
Jianliang Song (68 yo)
2.9yrs
Tenure
CN¥933,000
Compensatie
Mr. Jianliang Song serves as an Executive Director at Raily Aesthetic Medicine International Holdings Limited and serves as its Chief Executive Officer since December 28, 2021. Mr. Song is responsible for...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Executive Chairman of the Board | 6.8yrs | CN¥852.00k | 53.1% HK$ 35.5m | |
| CEO & Executive Director | 2.9yrs | CN¥933.00k | geen gegevens | |
| Chief Financial Officer | no data | CN¥433.00k | geen gegevens | |
| Executive Director | 2.9yrs | CN¥558.00k | geen gegevens | |
| Company Secretary | 4yrs | geen gegevens | geen gegevens |
3.5yrs
Gemiddelde duur
47yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van 2135 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.5 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Executive Chairman of the Board | 6.8yrs | CN¥852.00k | 53.1% HK$ 35.5m | |
| CEO & Executive Director | no data | CN¥933.00k | geen gegevens | |
| Executive Director | 2.9yrs | CN¥558.00k | geen gegevens | |
| Independent Non-Executive Director | 3.9yrs | CN¥162.00k | geen gegevens | |
| Independent Non-Executive Director | 3.9yrs | CN¥162.00k | geen gegevens | |
| Independent Non-Executive Director | 3.9yrs | CN¥162.00k | geen gegevens |
3.9yrs
Gemiddelde duur
48.5yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van 2135 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.9 jaar).